The largest database of trusted experimental protocols

Stemdiff mesoderm induction medium

Manufactured by STEMCELL
Sourced in Switzerland

STEMdiff Mesoderm Induction Medium is a cell culture medium designed to promote the differentiation of human pluripotent stem cells into mesoderm lineage cells. The medium supports the directed differentiation of stem cells towards mesodermal cell types such as cardiomyocytes, smooth muscle cells, and hematopoietic progenitors.

Automatically generated - may contain errors

7 protocols using stemdiff mesoderm induction medium

1

iPSC Culture and Differentiation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
All iPSCs were cultured as described previously (Roberts et al., 2017 (link)). Untagged iPSCs (Coriell Institute for Medical Research; GM25256) and mEGFP-tagged LMNB1 iPSCs (Allen Institute for Cell Science, Coriell; AICS-0013 cl.210) were grown in mTeSR and mTeSR Plus in cell culture dishes coated with Matrigel matrix (Growth Factor Reduced; Corning; 354230, or phenol-red-free; Corning; 356237). Matrigel was applied at a concentration of 137–154 µg/ml dissolved in PBS or DMEM. Cells were dissociated using Gentle Cell Dissociation Reagent (Stem Cell Technologies; 100-0485) or Versene Solution (Thermofisher Scientific; 15040066) and ROCK Inhibitor Y27632 at a final concentration of 10 µM (ATCC; ACS-3030). iPSCs were differentiated using STEMdiff Trilineage Differentiation Kit (Stem Cell Technologies; 05230) or STEMdiff Mesoderm Induction Medium (Stem Cell Technologies; 05220). All cells were maintained at 37°C at 5% CO2. Pluripotency and differentiation were confirmed using Oct4, Nanog, HNF-3β, Otx-2, and Brachyury antibodies in immunofluorescence assays.
+ Open protocol
+ Expand
2

Endothelial Differentiation of hiPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Endothelial-cell (EC) differentiation of hiPSCs was performed in monolayers of cultured hiPSCs with the STEMdiff Endothelial Differentiation Kit (STEMCELL Technologies) as directed by the manufacturer’s instructions. Briefly, hiPSCs were seeded into mTeSR Plus (STEMCELL Technologies) in a 6 well plate at a density of 5.0 × 104 per well and then on dD1 and dD2, the medium was changed to 3 ml STEMdiff Mesoderm Induction Medium (STEMCELL Technologies). The medium was replaced with 4 ml of STEMdiff Endothelial Induction Medium (STEMCELL Technologies) on dD3 and refreshed on dD5. On dD7, the cells were dissociated with ACCUTASE (Corning), transferred into a fibronectin-coated T75 flask, and cultured in EGM-2 MV (Lonza) supplemented with SB431542 (Fischer Scientific) until 100% confluent. Purification was performed by dissociating the cells, resuspending them in cold Dulbecco phosphate-buffered saline (DPBS) with 2% fetal bovine serum (FBS) at a density of 1 × 106 cells/100 μL, and then collecting cells that expressed both CD31 and CD144 via flow cytometry on a BD FACS Aria II instrument; 100-µL samples were labeled by incubating them with 5 µL of AlexaFluor-conjugated CD31 and 20 µL of phycoerythrin-conjugated CD144 antibodies for 45 min on ice and then washed in DPBS.
+ Open protocol
+ Expand
3

Generating iPSC-derived Mesenchymal Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
iPSCs were seeded without feeder cells on Matrigel at 5000 cells/cm2 and cultured in mTeSR Plus supplemented with ROCK pathway inhibitor Y-27632 (Enzo Life Sciences, Lörrach, Germany). After 24 h, the medium was changed to STEMdiff Mesoderm Induction Medium (STEMCELL Technologies) and replenished daily for four days. On day 5 of differentiation, medium was replaced with StemXVivo MSC Expansion Medium (R&D Systems, Minneapolis, MN, USA). After 48 h, cells were dissociated with 0.25% trypsin/EDTA (Thermo Fisher Scientific) and seeded onto gelatin-coated plates at 1  ×  104 cells/cm2 in MSC expansion medium. Medium was replenished every other day, and cells were propagated to 80% confluence in a humidified atmosphere at 37 °C and 5% CO2. The differentiated cells derived from these culture conditions were termed iPSC-derived MSCs (iMSCs) and expanded. Cells of an early passage were used for characterization. For routine expansion, cells were plated at 5  ×  104 cells/cm2 onto Matrigel or uncoated culture dishes (starting with P3) and maintained in MSC growth medium. MSC growth medium consisted of Dulbecco’s modified Eagle’s medium-high glucose (DMEM-HG; Thermo Fisher Scientific), 10% FBS, and 1% PS.
+ Open protocol
+ Expand
4

Differentiation of hPSCs into Neural, Endoderm, and Mesoderm

Check if the same lab product or an alternative is used in the 5 most similar protocols
Monolayer differentiation of hPSCs into neural stem cells was performed with Neural Induction Medium (Life Technologies). Neural progenitor cells were generated by using the STEMdiff Neural System EB protocol. For differentiation into endoderm, the TESR-E8 optimized STEMdiff Definitive Endoderm Kit was used. Mesoderm differentiation was performed using STEMdiff mesoderm induction medium (all from STEMCELL). All differentiations were performed according to the manufacturer's protocol. Dox was added when indicated (Figures 4A and S4B).
+ Open protocol
+ Expand
5

Directed Differentiation of hiPS Cells into Myotubes

Check if the same lab product or an alternative is used in the 5 most similar protocols
hiPS cells were cultured on iMatrix-511 (Nippi) in StemFit AK02N culture medium (Ajinomoto) and induced into the mesoderm lineage using STEMDiff Mesoderm induction medium (Stem Cell Technologies). After 3 d culture, the cells were cultured as spheres [12 (link)]. After 6 wk culture, the cells were plated onto collagen-coated plates and infected with a lentiviral vector encoding a doxycycline (dox)-inducible mouse MyoD gene (pLVi(3G)-TagGFP-E2a-MYOD-Puro, Sirion Biotech). After 2 d selection with puromycin (1 μg/ml) (Calbiochem) and dox (1 μg/ml) (LKT Laboratories) selection, the cells were induced to form myotubes in the presence of dox in DMEM supplemented with 2% horse serum. Multinucleated myotubes were immunostained with Hoechst 33258 dye (nuclei), antidystrophin polyclonal antibody (Abcam), and antimyosin heavy chain (MF20) (R&D Systems), and then visualized with goat anti-mouse IgG2b-Alexa568 and goat anti-rabbit IgG-Alexa 488 (Life Technologies).
+ Open protocol
+ Expand
6

Efficient Stem Cell Differentiation Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
Endoderm and mesoderm differentiations were induced using the TeSR-E8 optimized STEMdiff Definitive Endoderm Kit (STEMCELL Technologies) or STEMdiff Mesoderm Induction Medium (STEMCELL Technologies). Endoderm and mesoderm cells were analyzed on day 5. Ectoderm differentiation was induced using E6 medium supplemented with LDN-193189 (100 nM, Tocris) and A83-01 (2 μM, Tocris) and cells were analyzed on day 7. All automated and manual protocols were performed in parallel as described in the supplemental information.
+ Open protocol
+ Expand
7

Differentiation of hiPSCs into Endothelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human induced pluripotent stem cell line, hFSiPS1, was kindly provided by the National Stem Cell Bank of Korea (Korea National Institute of Health). The hFSiPS1 cells were maintained in an hESC-qualified Matrigel (Corning, NY, USA) coated dish in mTESR1 (Stem Cell Technologies, CA, USA). For endothelial differentiation, the hiPSCs were dissociated using Accutase (Stem Cell Technologies) and then seeded on Matrigel at a density of 1.5 × 105 cells per well in a 6-well dish with mTESR1 containing 10 μM Y-27632 (Stem Cell Technologies). After one day, the cells were washed once with PBS, and then Stemdiff Mesoderm induction medium (Stem Cell Technologies) supplemented with 1 μM CP21R7 (Roche, Switzerland) was added. After three days, the medium was replaced by an endothelial cell induction medium consisting of StemPro-34 SFM medium (Life Technologies, USA) supplemented with 200 ng/mL VEGF-A (Peprotech, USA) and 2 μM forskolin (Sigma-Aldrich) for 2 days. After endothelial cell induction, medium was replaced with EGM-2 (Lonza) medium supplemented with 50 ng/mL VEGF165 (Peprotech) and 1 μM BMX for endothelial cell maturation.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!